⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2420397 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL28241321 | 0.98 | CA1 (0.39) | — | |
| SCHEMBL14687523 | 0.86 | CA2 (0.52) | — | |
| SCHEMBL3248461 | 0.86 | CA2 (0.52) | — | |
| SCHEMBL14819788 | 0.85 | CA1 (0.45) | — | |
| SCHEMBL8252887 | 0.83 | — | — | |
| SCHEMBL10207367 | 0.83 | — | — | |
| SCHEMBL22577460 | 0.83 | GPR84 (0.44) | — | |
| SCHEMBL16327658 | 0.83 | GPR84 (0.44) | — | |
| SCHEMBL31520092 | 0.83 | GPR84 (0.44) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105481862-B | novel inhibitors of F L T3 kinase and uses thereof | 中国科学院合肥物质科学研究院 | 2018-08-21 | — | — | CN | claimed |
| EP-2102229-A1 | PYRROLYDINE DERIVATIVES AS IAP INHIBITORS | Novartis AG (CH) | 2009-09-23 | — | — | EP | claimed |
| WO-2008045905-A1 | PYRROLYDINE DERIVATIVES AS IAP INHIBITORS | NOVARTIS AG (CH) | 2008-04-17 | — | — | WO | claimed |
| WO-2024112809-A2 | CELL-PENETRATING PEPTIDES, CONJUGATES THEREOF, AND METHODS OF THEIR USE | PEPGEN INC. (US) | 2024-05-30 | — | — | WO | disclosed |
| EP-3784669-B1 | PTERIDINONE COMPOUNDS AND USES THEREOF | VERTEX PHARMA (US) | 2023-10-25 | — | — | EP | disclosed |
| EP-3744719-B1 | THIOPHENE DERIVATIVE AND USE THEREOF | FUJIMOTO CO LTD (JP) | 2023-06-07 | — | — | EP | disclosed |
| WO-2023072971-A2 | GASTRIC INHIBITORY PEPTIDE RECEPTOR LIGANDS | 3B PHARMACEUTICALS GMBH (DE) | 2023-05-04 | — | — | WO | disclosed |
| US-20230027739-A1 | ANTIGEN-BINDING AND ANTIGEN DEGRADATION CONSTRUCTS | ENTRADA THERAPEUTICS, INC. | 2023-01-26 | — | — | US | disclosed |
| US-20180273529-A1 | BICYCLIC COMPOUND AND USE THEREOF FOR INHIBITING SUV39H2 | ONCOTHERAPY SCIENCE, INC. (JP) | 2018-09-27 | — | — | US | disclosed |
| CN-105481862-B | novel inhibitors of F L T3 kinase and uses thereof | 中国科学院合肥物质科学研究院 | 2018-08-21 | — | — | CN | disclosed |
| EP-2989086-A1 | DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | Pierre Fabre Médicament (FR) | 2016-03-02 | — | — | EP | disclosed |
| WO-2014174060-A1 | DERIVATIVES OF DOLASTATIN 10 AND AURISTATINS | PIERRE FABRE MEDICAMENT (FR) | 2014-10-30 | — | — | WO | disclosed |
| US-20130041178-A1 | METHOD FOR PREPARING OPTICALLY ACTIVE N-METHYLAMINO ACIDS AND OPTICALLY ACTIVE N-METHYLAMINO ACID AMIDES | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2013-02-14 | — | — | US | disclosed |